|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-9-27
|
|
pubmed:abstractText |
To determine the pharmacokinetic (PK) and glucodynamic (GD) dose response of human insulin inhalation powder (HIIP) delivered via AIR particle technology and dose equivalence to subcutaneous (SC) insulin lispro.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2400-5
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16186270-Administration, Inhalation,
pubmed-meshheading:16186270-Adult,
pubmed-meshheading:16186270-Cross-Over Studies,
pubmed-meshheading:16186270-Diabetes Mellitus, Type 1,
pubmed-meshheading:16186270-Female,
pubmed-meshheading:16186270-Glucose Clamp Technique,
pubmed-meshheading:16186270-Humans,
pubmed-meshheading:16186270-Hypoglycemic Agents,
pubmed-meshheading:16186270-Injections, Subcutaneous,
pubmed-meshheading:16186270-Insulin,
pubmed-meshheading:16186270-Insulin Lispro,
pubmed-meshheading:16186270-Male,
pubmed-meshheading:16186270-Metered Dose Inhalers,
pubmed-meshheading:16186270-Powders,
pubmed-meshheading:16186270-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.
|
|
pubmed:affiliation |
Profil Institut für Stoffwechselforschung, Hellersbergstr. 9, D-41460 Neuss, Germany. klaus.rave@profil-research.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
